Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering. Get the exact trades and sectors to target ...

The recent outbreak of the mpox virus has thrown companies like Tonix Pharmaceuticals (TNXP) into the limelight as it presses ahead with the preclinical development of its mpox vaccine candidate, ...

We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands ...

Following the approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) initiated the commercial ...

Tonix remains rated Hold as Tonmya's commercial launch underwhelms, with Q1 2026 net product revenue at $3.7m. Read more on ...

Here’s a basic investment overview of two small-cap NASDAQ biotechs with 2025 PDUFAs: Tonix Pharmaceuticals (TNXP) and Crinetics Pharmaceuticals (CRNX).Mechanism: Sublingual formulation of ...

Fintel reports that on February 28, 2024, Dawson James initiated coverage of Tonix Pharmaceuticals Holding (NasdaqCM:TNXP) with a Buy recommendation. As of February 24, 2024, the average one-year ...

(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial-stage biotechnology company, announced that members of its management team will participate in ...

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ...